期刊
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 176, 期 9, 页码 1972-1975出版社
WILEY
DOI: 10.1002/ajmg.a.40370
关键词
hyperphagia; infancy-onset obesity; MYT1L
资金
- Lastentautien Tutkimussaatio
- Novo Nordisk Foundation
- Paivikki ja Sakari Sohlbergin Saatio
- Samfundet Folkhalsan
- Sigrid Juseliuksen Saatio
- Suomen Akatemia
- Vetenskapsradet
The genetic background of severe early-onset obesity is still incompletely understood. Deletions at 2p25.3 associate with early-onset obesity and variable intellectual disability. Myelin-transcriptor-factor-1-like (MYT1L) gene in this locus has been proposed a candidate gene for obesity. We report on a 13-year-old boy presenting with overweight already at 1 year of age (body mass index [BMI] Z-score +2.3) and obesity at 2 years of age (BMI Z-score +3.8). The patient had hyperphagia and delayed neurological, cognitive and motor development. He also had speech delay, strabismus, hyperactivity and intellectual disability. Brain MRI was normal. The parents and sister had normal BMI. Whole-genome sequencing identified in the index patient a novel de novo frameshift deletion that introduces a premature termination of translation NM_015025.2(MYT1L): c.2215_2224delACGCGCTGCC, p.(Thr739Alafs*7) in MYT1L. The frameshift variant was confirmed by Sanger sequencing. Our finding supports the association of MYT1L mutations with early-onset syndromic obesity. The identification of novel monogenic forms of childhood-onset obesity will provide insights to the involved genetic and biologic pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据